OptimizeRx Corp

詳細情報 OptimizeRx Corp 企業名

OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.

企業情報

企業コードOPRX

会社名OptimizeRx Corp

上場日May 18, 2005

最高経営責任者「CEO」Mr. Stephen L. (Steve) Silvestro

従業員数106

証券種類Ordinary Share

決算期末May 18

本社所在地260 Charles Street

都市WALTHAM

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号02453

電話番号12486516558

ウェブサイトhttps://www.optimizerx.com/

企業コードOPRX

上場日May 18, 2005

最高経営責任者「CEO」Mr. Stephen L. (Steve) Silvestro

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. James (Jim) Lang

Independent Director

386.03K

+2.62%

Mr. Stephen L. (Steve) Silvestro

President, Chief Executive Officer, Director

119.10K

+65.06%

Ms. Theresa Greco

Chief Commercial Officer

62.93K

+17.74%

Mr. Doug Besch

Chief Product Officer and Chief Technology Officer

51.60K

-2.62%

Mr. Edward (Ed) Stelmakh

Chief Financial Officer, Chief Operating Officer

46.65K

-47.02%

Mr. Gregory D. (Greg) Wasson

Independent Director

43.90K

+29.00%

Mr. Patrick D. (Pat) Spangler

Independent Director

42.05K

+30.66%

Ms. Catherine M. Klema

Independent Director

14.98K

+193.15%

Ms. Marion K. Odence-Ford

General Legal Officer and Chief Human Resources Officer

--

Mr. Andy Dsilva

Investor Relations

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. James (Jim) Lang

Independent Director

386.03K

+2.62%

Mr. Stephen L. (Steve) Silvestro

President, Chief Executive Officer, Director

119.10K

+65.06%

Ms. Theresa Greco

Chief Commercial Officer

62.93K

+17.74%

Mr. Doug Besch

Chief Product Officer and Chief Technology Officer

51.60K

-2.62%

Mr. Edward (Ed) Stelmakh

Chief Financial Officer, Chief Operating Officer

46.65K

-47.02%

Mr. Gregory D. (Greg) Wasson

Independent Director

43.90K

+29.00%

収益内訳

データなし

データなし

事業別

地域別

データなし

株主

更新時刻: Wed, Jul 2

株主統計

種類

株主統計

比率

Whetstone Capital Advisors, LLC

8.16%

Weintraub (Michael)

7.49%

BlackRock Institutional Trust Company, N.A.

6.31%

The Vanguard Group, Inc.

4.98%

Royce Investment Partners

4.27%

Other

68.79%

株主統計

比率

Whetstone Capital Advisors, LLC

8.16%

Weintraub (Michael)

7.49%

BlackRock Institutional Trust Company, N.A.

6.31%

The Vanguard Group, Inc.

4.98%

Royce Investment Partners

4.27%

Other

68.79%

種類

株主統計

比率

Investment Advisor

27.45%

Investment Advisor/Hedge Fund

20.20%

Individual Investor

15.64%

Hedge Fund

9.85%

Research Firm

5.12%

Bank and Trust

0.09%

Insurance Company

0.04%

Pension Fund

0.03%

Other

21.57%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

260

14.87M

80.40%

-7.61M

2025Q1

267

15.34M

83.16%

-6.19M

2024Q4

295

14.49M

78.68%

-4.45M

2024Q3

303

15.96M

87.07%

-2.38M

2024Q2

340

16.48M

89.93%

-3.43M

2024Q1

347

15.94M

87.64%

-3.60M

2023Q4

378

15.63M

86.21%

-4.61M

2023Q3

399

14.49M

86.61%

-5.94M

2023Q2

406

14.23M

85.34%

-7.19M

2023Q1

407

14.85M

86.69%

-4.67M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Whetstone Capital Advisors, LLC

1.51M

8.16%

--

Apr 18, 2025

Weintraub (Michael)

1.38M

7.49%

--

Apr 29, 2025

BlackRock Institutional Trust Company, N.A.

1.17M

6.31%

+5.50K

+0.47%

Mar 31, 2025

The Vanguard Group, Inc.

921.85K

4.98%

-13.71K

-1.47%

Mar 31, 2025

Royce Investment Partners

994.30K

5.38%

-75.26K

-7.04%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

631.03K

3.41%

+29.65K

+4.93%

Mar 31, 2025

Rice Hall James & Associates, LLC

576.17K

3.12%

-1.57K

-0.27%

Mar 31, 2025

Febbo (William J)

530.85K

2.87%

-83.11K

-13.54%

Apr 29, 2025

Kennedy Capital Management LLC

478.40K

2.59%

-115.60K

-19.46%

Mar 31, 2025

Parkman Healthcare Partners LLC

475.00K

2.57%

+475.00K

--

Mar 31, 2025

詳細を見る

12.765USD

OptimizeRx Corp

12.765

概要

企業名

金融